China Hot Sale Lenvatinib Mesylate Powder CAS 857890-39-2 for Thyroid Cancer, Find details about China Lenvatinib Mesylate [Usan];, Lenvatinib Mesylate from Hot Sale Lenvatinib Mesylate Powder CAS 857890-39-2 for Thyroid Cancer
Product name | Lenvatinib Mesylate |
CAS | 857890-39-2 |
Package | Option to customer |
Molecular Formula | C21H19ClN4O4.CH4O3S |
Molecular Weight | 522.96 |
Lenvatinib Mesylate is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well.
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).
Fuction and Application of Lenvatinib Mesylate :
It is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
Function :
Items | Specifications | Results | |
Appearance | A white or off white crystalline powder | White crystalline powder | |
Solubility | Freely soluble in chloroform | Conform | |
Specific rotation(0)[α]D20 | +75~+84 | +78.6 | |
Loss on drying(%) | ≤1.0 | 0.73 | |
Residue on ignition(%) | ≤0.1 | 0.03 | |
Heavy metals(ppm) | ≤20 | conform | |
Metling point() | 178-193 centi-degree | 186-190centi-degree | |
Purity(HPLC,%) | ≥98.0 | 99.6% | |
Related substances(HPLC) | Single impurity: ≤0.5% Total impurity: ≤1.0% | Conform |
FAQ
· Q:What is the MOQ?
· A:1kg. But usually, we accept less quantity such as 100g on the condition that sample charge is 100% paid.